CE

julian_jakobi

Indeed. Please see this great interview with Steve Harrison, CEO of Clyra Medical, and Dennis Calvert, CEO of BioLargo which updates everyone on the significant commercial activities underway and a few highlights the are worth noting. You can watch the interview here: https://www.youtube.com/watch?v=Zp1VRjV6Btg Notice a few highlights: * Sales commencing in the wound care industry ASAP with signing of advanced solution distribution agreement. * Surgical products in final stages of preparation for launch with industry-leading partner. * Clinical evidence underway with key opinion leaders and publication expected Q1. * International sales to begin ASAP subject to the completion of paperwork (already underway) for the CE mark required for sales in Europe, the Middle East, and Northern Africa. * Most recent capital inflow to Clyra at USD $100 Million valuation and BioLargo still owns 48% plus its royalty. * Products have a chance to become the “standard of care”. If you haven’t taken a look at the Clyra website in a while, be sure to notice the exceptional professionals who are surrounding the company and its products: https://www.clyramedical.com/advisoryboard

Intelligent_Hat_136

After we took resistance at 6790 at open I sold 6830 and when we got to 6770 I added a 6815 CE short(this fucked my day starting here) the sudden spike to 6815 set me back, I added another 6830 and 6825 and shorted 6800 PE and 6790 PE which again go fucked cause of the sudden drop, had to close the puts and rolled the calls down to 6780CE which again got run into. Man I couldn’t catch a break today. All these are with 20 wide hedges

AvocadoPurees

CE lectures blasting in the background, futures on 2nd screen, plugging away at work. Thanks AI for boosting my productivity

PerfectInAllThings

Bubbles in the Dresser Formation in Australia are 3.48 billion years old. By my calculations that suggests AI bubble could last at least until year 3,480,002,025 CE

Special_Economist803

Orcle CE holders account Washout 🤣🤣😂

WendyDumpsterFire

Bullish on Comcast next year: Broadcasting the FIFA World Cup next year, opening a new theme park in Texas, and also lots of new movies that will hit box office records. [Discussion I did in a different thread] (https://www.reddit.com/r/ValueInvesting/s/9qS1K7CE9h)

ThreeQuartersSerious

Not really insane, just obscure. The Dreamcast was a Windows CE machine, Microsoft was heavily involved in the hardware design, and most of sega’s dev teams pivoted to Xbox initially. For a good while in the early 2000s, there was strong belief that Microsoft was buying out sega’s entertainment business. Without Sega’s influence, the Xbox would’ve been a normal windows HTPC.

Krammsy

I don't know what I'm looking at, you're in a foreign market, I don't know what "PE" or "CE" stand for. You're better off describing it.

Icy_Bookkeeper_208

I'm sorry, Jon.  -  An AI generated Garfield gif uncovered among the ancient ruins. Circa 2025 CE.

TherealCarbunc

depends on the EU rollout. It got CE mark approval in June and has gotten $900k in orders so far that has been publicized. $400k from Spain and 900k from France. Positive signs it should started improving. it also partnered with the Carolina Fertility institute to offer FemaSeed. I have a feeling earnings may be better than I was initially expecting

ChristopherMiles21

Quest + CE data = legit combo, this could 5x on good feasibility read

ragnaroksunset

The entire point of DCA / buy and hold is that you don't give yourself the option to panic sell at the bottom because you stick to your purchasing plan. It's *designed* to overcome psychology. Once you introduce a decision point into the approach, you introduce a vector for psychology to enter back into the game. Then you get burned twice - once when you fail to time your divestment of the CE index, and again when you fail to time your re-entry - instead of zero times because you held through the drop and recovery.

Complex-Jello-2031

FemBloc is legit - CE marked in Europe (March 2025), approved in New Zealand (September 2025). The product works and addresses a real need. But you're right that U.S. FDA approval and meaningful revenue are 2-3 years out minimum. They just got FDA approval on November 3rd to continue their final trial phase (Part B), but that's just enrollment starting. Best case scenario you're looking at 2027-2028 for U.S. approval, and that's if everything goes perfectly. The bigger issue is the financing. They secured $12M in convertible notes with the trial news, but they're burning $4.5M per quarter with only $3.2M in cash. So more dilution is coming within 6-9 months. Current revenue is basically nothing - $409K last quarter. M&A potential is there eventually. At $36M market cap they're cheap enough for Bayer, Organon, or another women's health player to scoop up. But strategic buyers typically wait for FDA clarity. Nobody's paying a premium for a Phase 3 asset with years of trial risk and capital needs ahead. So yeah - legitimate science, real regulatory progress internationally, but the U.S. story and any M&A action is 2027+ if it materializes at all. The November 3rd pop already priced in the trial continuation news.

Complex-Jello-2031

You nailed it. That's exactly right. FemBloc is a real product with CE Mark in Europe and approval in New Zealand. But U.S. FDA approval is years away - they just got approval to start the final trial phase on November 3rd. Even if everything goes perfectly, you're looking at 2027-2028 for U.S. market entry. The cash situation is the real problem. They're burning through $4.5M per quarter and just raised $12M via convertible notes. That buys them maybe 6-9 months before they need more money, which means more dilution coming. M&A is possible down the road since the market cap is only $36M, but buyers will wait for more FDA clarity. Too much execution risk right now. But at this price point even if it does not work out you can usually still make money & they are not pure spec so the chances of collapse are minimal. Would a take a giant stake no but is it worth a small spec position Definitely. My key to these is buy the dips & trim 10% during the spikes that keeps your basis low & clears some risk

Aggressive-Bobcat-87

Massive news! Disruptive! 2.5 Mio pot. Interventionen just US with new patent up to 6 Mio Intervention just in the US End of 2026: MDR CE Approval, another pot. multimillion interventions TAM around 30 Billion in 2030

crunchsoop

I don't think that is his point. I think he sees the light. How in the shit balls can a $1.5t company pay a $1t pay package and have funds be excited about the prospects? Because their CE-bro tweets they "might" release a flying get. This shit is Ludacris. No offense to 90s hi hop.

stickman07738

DOW, CE and LYB are highly commoditized business with numerous competitor and as I stated ASH has been cleaning up and exiting their poor performing segments. I am waiting for ASH next quarterly report and expecting drastic improvements in gross profits.

MaleficentPositive53

ASH seems to be trading no differently than DOW, CE, LYB. The company seems to be facing the same sector risks.

Constant_Story8217

2026 and it's a remake of CE

logikok

Zinc is interesting because it has so much potential... But I've been reading that technically it's not there yet Taken from: https://www.sciencedirect.com/science/article/abs/pii/S0925838825000131 "Significant problems include zinc dendrites, the hydrogen evolution process (HER), and corrosion and passivation caused by the thermodynamic instability of the zinc anode. Low Coulombic Efficiency (CE) is caused by side reactions that deplete the electrolyte and zinc anode."

WaveZealousideal2848

I'm in both 

salty0waldo

There are a lot of factors causing this, and I think prior comments hit on the big ones. Commodity chemicals like PP and PE are in a massive oversupply with weak demand, think DOW/LYB/CE. Demand is an issue, but also China is dumping alot of cheap products into the market, which is putting strain on margins. Also, low oil prices hurt the margins. The industry was not prepared for such a prolonged downturn as well, so after a while the impact on the balance sheet became amplified (IMO). Specialty chemicals like DD, Corteva, EMN, and CC are expected to stabilize in Q3/Q4.

Future_Hyena2562

I was on a call last summer for CFP CE and they were pamping the hell out of gold. You think I would have been smart enough to listen.

NaluknengBalong_0918

Didn’t know they sell CE trim…

StreetAd3301

You missed the part, if you brought a stock for 1000$ today, and after 3 months it crashes to 600$ and then you sell covered call for 700 CE and unfortunately it expires deep ITM then you are forced to not only sell your stock at a loss of 400  but additionally also book loss on the sold deep ITM call option. There is no free lunch buddy !!

VastCar6051

"**Forget about it until it's on PubMed? It's already there.** You must not have done your search properly. Research papers related to the Lumee Oxygen Platform have been **officially indexed on PubMed Central (PMC)**, a part of the U.S. National Institutes of Health, since at least 2018. This proves that there is formal scientific literature available, not just a CE Mark. Furthermore, the reliability of this technology is already being validated in the clinic. The Lumee system is actively used by **Prof. Dr. Marianne Brodmann, the respected principal investigator for the Lumee Oxygen CE Mark studies**, in her own practice for approximately **1,500 vascular procedures annually**. A world-leading expert is confirming its critical clinical need. Finally, while you point out the lack of comprehensive CGM data, the **true value** of this technology lies in its **unparalleled long-term durability** and **market potential**. Standard CGM sensors like Abbott’s FreeStyle Libre are limited to **14 to 15 days**. In stark contrast, the Lumee hydrogel sensor is designed and shown to function for up to **two years** inside the body. This is a **unique technological advantage** only possible with an injectable sensor. Crucially, the glucose sensor (CGM) technology Profusa is developing targets a massive global market estimated at **₩15 trillion (approx. $11 billion)**. For context, **Abbott, the current CGM market leader, has a market cap exceeding ₩300 trillion (over $220 billion)**, yet Profusa, which owns this disruptive technology, is valued at **less than ₩20 billion (under $15 million)**. What we are discussing is not just a simple device, but the **dawn of a new era of 'bio-integrated sensors' that fully merge with the human body.** Instead of focusing on current clinical data figures, please look at the **bigger picture of human health innovation that Profusa is spearheading.** I am confident that it will surpass the growth trajectory of its competitor Abbott and even the early growth of **Nvidia**."

NikWih

Nice story, but they only claim to have a CE mark for Lumee Oxygen. They have no feets on the ground in Europe, they have no clinical data to back up their CGM story and WORSE - why are they not selling their oxygen measurement device? Maybe because there are already sufficient devices in the market and they do not get reimbursement? Just tell an agent to look until they put something up in [pubmed.gov](http://pubmed.gov) , but until then, straight up forget about this

PaperHandsTheDip

The only way I can think of to scale this is to hire a bunch of guys to manually input the shit for you. Crowdsource accounts and do arb between different accounts / names. You can obfuscate all your arbs if you have multiple people. Difficulty of figuring it out who is "in the group" and who isn't grows exponentially as people increase linearly due to combinations of accounts you can arb inbetween. For example - a group of 6 people may be enough to run a sophisticated arb operation on. We know bookies blacklist people / talk to each other (just like casinos) -- so you gotta be smart about it. For example - if you have 6 accounts / people, A,B,C,D,E,F. You arb between A (long) and B (short) on two different brokers. You can do the combinations AB AC AD AE AF \-- BC BD BE BF \-- CD CE CF \-- DE DF \-- Never run the arb between two accounts with the same name. This gives you 14 unique ways to run arbs while minimizing risk of getting caught. With 10 people you basically can run hundreds of arbs in different combinations. Obfuscation is one way to remain undetected.

Bittygirl707

$clov Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice # The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value October 15, 2025 08:30 ET  | Source: [Clover Health Investments, Corp.](https://www.globenewswire.com/en/search/organization/Clover%2520Health%2520Investments%CE%B4%2520Corp%C2%A7) [https://www.globenewswire.com/news-release/2025/10/15/3167077/0/en/Clover-Health-s-2026-Medicare-Advantage-Plans-Champion-Affordability-and-Choice.html](https://www.globenewswire.com/news-release/2025/10/15/3167077/0/en/Clover-Health-s-2026-Medicare-Advantage-Plans-Champion-Affordability-and-Choice.html)

Birkanugaris

[https://www.globenewswire.com/en/search/organization/Processa%2520Pharmaceuticals%CE%B4%2520Inc%C2%A7](https://www.globenewswire.com/en/search/organization/Processa%2520Pharmaceuticals%CE%B4%2520Inc%C2%A7) in 2mins, in 32mins or in 1hr2mins by most used time in their PRs

StocksRup-1

This list is excluding FEMY’s which has analyst targets exactly 10x current price. Currently trading at .65 and average analysts are $6 bucks with a high of $8. FEMY should be added based on current mkt cap and huge opportunity with a product mix already developed either CE marks globally with zero competitors

The_Brand94

I think what most people are missing here is that specialty chemicals and products companies like DOW, LYB, and CE produce will be used largely in the physical infrastructure build out for AI. 2026 likely to be a lower rate environment, construction picks up. I mean all these big tech companies are circle jerking money without much of the needed utilities and physical infrastructure being complete yet. They need land, buildings with most up to date materials/planning, and the draw they will put on the electrical grid. The physical construction portion of the build out for AI has really yet to be seen and I think we will see a lot more activity in 2026.

Bittygirl707

$CLOV Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant # New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets October 06, 2025 16:30 ET  | Source: [Clover Health Investments, Corp.](https://www.globenewswire.com/en/search/organization/Clover%2520Health%2520Investments%CE%B4%2520Corp%C2%A7) [https://www.globenewswire.com/news-release/2025/10/06/3162116/0/en/Counterpart-Health-Expands-Leadership-to-Accelerate-Enterprise-Partnerships-and-Regional-Adoption-of-AI-Powered-Platform-Counterpart-Assistant.html](https://www.globenewswire.com/news-release/2025/10/06/3162116/0/en/Counterpart-Health-Expands-Leadership-to-Accelerate-Enterprise-Partnerships-and-Regional-Adoption-of-AI-Powered-Platform-Counterpart-Assistant.html)

Tracen4justice

I have diabetes and I am using Libre3. Every 15 days I have to change the sensor which is always painful Additionally my arm is full of needle marks. The Libre3 delivers not always the correct values and so I have to do additional bloody measurements. I am just waiting for the CE permission and then, directly after it is available in Switzerland or Germany, I will take it. 365 days without the button on my arm, that's what I am really waiting for.

StocksRup-1

100% agree!!!!!! Discovered this stock in May 2024. The addressable market, approved CE, pending FDA, new funding. People will be sorry for missing this one.

Physical-Hall-2028

Get in as soon as possible.... In my opinion there will be a big squeeze soon given the hype it is generating. For the price at the end of the week I don't have a precise limit, think that this stock was at 1.89 and last February, it had dropped because it didn't have financing... Now that the financing for expansion and production has arrived, I would expect it to reach at least 1.5 dollars, and much more beyond that, given the recent developments (e.g. obtaining the CE mark and expansion into the European market). It is a microcap that is currently flying under the radar, analysts have price targets between $5 and $13, with an average of $5.67, and with "Strong buy" ratings. If they perform even in modest quantities, the potential upside could be enormous... However, do your own evaluations first.

Physical-Hall-2028

They are not a pump and dump, and FEMY is just starting its run..... Those who get in by the beginning of next week will have a big advantage. FEMY is flying under the radar. Among many things, this company has no competitors for non-surgical contraception, and has just begun to expand marketing of its Fembloc product, after obtaining the CE mark, in Europe. It has received recent commercialization funding. She recently published the positive results of her IVF test, Femaseed. The market is potentially huge. This stock was at 1.89 last February, and had dropped because it had no financing... Now that financing for expansion and production has arrived, I expect it to reach at least 2.5 dollars, or much more, given recent developments (e.g. expansion into the European market). Analysts have price targets between $5 and $13, averaging $5.67, with “Strong buy” ratings from brokerage firms.

StocksRup-1

This stock was at 1.80 on 2/20/25. It dipped down to a lack of funding. Not that funding has been secured, they have the time now to sell and increase revenues. Given their product mix and continuing CE approvals, I expect revenues will drive this to $2 in the short term based on valuation alone.

Neat-Excitement-53

I know we have our stocks for Next weak. But I want to bring attention to SENS.  I heard about it here and it seems they made the CE Mark submission on February, 2025 and the may be launch their product in Europe this year. Stock price seems decent 

netflix-ceo

CE Oh no he di'nt

ALMessenger

The idea that you buy a stock when people are pessimistic about it (and more likely to undervalue it) seems like a good starting point to me. I like a stock that is red on the 5 year chart. CE, CBRL, LULU, and ENPH are ones that I have high hopes for. You always need to be cautious though since there is no guarantee a company will not drop further (or even be around long term)

Mharciello

Never forget: https://www.reddit.com/r/wallstreetbets/s/DaD45Yw8CE

Natural_Flamingo9365

2019 The ReStore exo-suit for stroke rehabilitation received FDA & CE clearances for sale to rehabilitation clinics in the United States and within the European Union * 2020 Finalized agreements with key German payors for the supply of ReWalk Personal 6.0 to qualified patients; * Amended our research collaboration agreement with Harvard to focus on tele-health solutions and extend the term through March 2023; * Entering upper and lower extremity products, offering hand, leg, arm and balance systems with MediTouch * Adding functional electrical stimulation cycle for home and rehab therapy with Myolyn; and * The Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons. * Received Medicare Provider certification from the Centers for Medicare & Medicaid Services ("CMS"); * Completed additional contract with a German payor * Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage 2021: The Company entered into a contract with BKK Mobile Oil health insurance to supply ReWalk’s Personal 6.0 System to eligible persons in Germany; Additional five BKK partners have joined the operating contract in Germany * Received FDA breakthrough device designation for ReBoot, a soft exoskeleton for stroke home and community use

pew_pew420420

Let's ride 

Ok-Albatross-3804

Possible recession on the table with rates cuts. Looking at recession proof stocks..$CERS According to Wall Street analysts, the average 1-year price target for CERS is 4.76 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD. Record Revenue: Cerus delivered record Q2 product revenue of $52.4 million, up 16% year-over-year, driven by strong demand for the INTERCEPT Fibrinogen Complex (IFC) and platelets. Guidance Raised: The company raised its full-year 2025 product revenue guidance to $200–$203 million (from $194–$200 million), with IFC sales outlook increased to $16–$18 million. IFC Momentum: IFC revenue nearly doubled quarter-over-quarter, and first-half IFC revenue almost surpassed all of 2024, reflecting greater hospital adoption and improved supply. Profitability Progress: Cerus achieved its fifth consecutive quarter of positive non-GAAP adjusted EBITDA, reporting $935,000 for Q2. Product Launches & Expansion: The new INT200 Illuminator launched in EMEA with positive customer feedback and regulatory approvals in multiple countries; CE Mark for red blood cell program in Europe expected in second half of 2026. Stable Margins: Gross margin remained steady at 55.2%, with management expecting margins to stay in the mid-50s for the balance of the year.

youlook_likeme

**Novocure** **Japan:** Novocure began NSCLC treatment in Japan after receiving regulatory approval on September 15, 2025. **Germany:** The launch and local availability of NSCLC treatment started in Germany earlier in 2025, following EU-wide CE Mark approval in April. **Spain:** Although covered by the EU-wide CE Mark since April, NSCLC treatment has not yet been launched or received public funding approval in Spain as of September 2025.  Also, two significant submissions with the FDA: **Pancreatic Cancer:** A Premarket Approval (PMA) application was submitted in August 2025 for its Optune Lua device for locally advanced pancreatic cancer, with an FDA decision expected in the second half of 2026. **Brain Metastases:** Based on positive results from the Phase 3 METIS trial, the company plans to submit a PMA application in the second half of 2025 for treating brain metastases from non-small cell lung cancer (NSCLC).

some_random_nonsense

It's not really my place to engage in pseudohistorical theorizing, but I would challenge one of the major examples in the quoted text: late Rome. The author here seems to be conflating a general idea that Rome was sexually libertine (when? it matters) with the eventual fall of the (likely) Western Roman Empire in the fifth century CE. And certainly there are some aspects here that are true. Romans of a certain class, after a certain point in the republic, did some freaky sex stuff. They also had lots of sex outside of marriage. Julius Caesar (d. 44 BCE), famously, had lots and lots of affairs. Emperors like Tiberius (d. 37 CE) and Nero (d. 69) were infamous for their sexual escapades and deviance. When we turn to a work of fiction, like Petronius' *Satyrica* (ca. 65 CE?), we find all sort of sexual libertinism. Like, tons of it. All sorts of weird combinations, stuff that would boggle your mind (and boggles students' minds today). Quick plug, here, for the Fellini *Satyricon* movie. It's weird, but so is the ancient text it's based on. And of course there's all the love poetry from guys like Catullus (d. 54 BCE), or Ovid's (d. 17/18 CE) *Ars Amatoria*. So yeah, the Romans, especially in the late Republic and early Imperial period, got up to some pretty freaky (and probably fun!) shit. They also did all sorts of horrible and awful things like systematically raping slaves and children (and child slaves) of both sexes, because that's what happens in a brutal slave society in which masculinity is deeply tied to the ability to penetrate (with swords, spears, or anything else). But they had been doing that for a loooong time: Amy Richlin's work on this is very good, as is Kathy Gaca's. And yes, eventually the Roman Empire fell. Not to get into the weeds on when, exactly, it fell (I think for all intents and purposes what happens after the 7th century CE is something totally new), but this person is most likely thinking of the Western Roman Empire, which collapsed over the middle decades of the fifth century CE, to be replaced by the "barbarian" successor states of the West. The canonical date for this, again all sorts of problems, is 476 CE. The main problem, here, is that the sexual libertinism of the Romans, which perhaps reached its peak in the first centuries of the common era, is... three or four or even five hundred years before the fall of the WRE. In fact, if you were to ask someone when the Roman Empire was at its height, it's when they were doing all the freaky stuff. You even have emperors like Hadrian (who is considered one of the best) who has a long term, very public homosexual relationship. Now, there is one major change having to do with sexuality that coincides with the fall of the Western Roman Empire: the rise of Christianity and the imposition of strict sexual norms against extramarital sex, homosexuality, and even in some cases against sex in general (the concept of holy virginity). Now, as a caveat, I don't think this has anything to do with the fall of the WRE, which has much more to do with transport costs, climate and environmental shifts, the incentive structures of the late Roman state, the rise of non-Roman confederacies, and a million things that have nothing to do with sex, but if you're a sex person, then you kind of have to wrestle with it. By the fifth century CE, the century in which the Empire collapses (in the West...), basically all of Roman society has converted to Christianity. With the rise of Christianity there is a new discourse that develops around the body, sin, desire, all that. Saint Paul, the most important figure in the development of Christian dogma, is famously ambivalent about sex, and the idea that sex should be restricted to marriage for procreation, if you're even going to have it, takes over. What we see in the decades leading up to the collapse of the West Roman state is in fact the total opposite of what the essay above argues. Rather than a period of sexual libertinism leading to imperial collapse, we find that the period of sexual libertinism is when the Empire is kicking ass and taking names. And it's the period in which there is a strict sexuality that denies non-procreative sex, or even sex in general, that sees imperial collapse. Again, I don't think these are related at all, but if you think that sex leads to the end of Empire, you can't use Rome as an example.

SecondSt4ge

Yeah I kinda have the same problem…servers have too many people that don’t help and I always get too much info or the wrong picks. Yeah I’m pretty deep into TXTM. I know some people that are already like 300% up because they got in before the CE ban lift. Once the ban lifted the stock jumped from 0.0001 to 0.005. That’s when I found out about it. It’s been fizzling down since then. But it’s still technically up. So I can’t say it’s doing bad. I just got in way too high and now price is dropping because there hasn’t been other major news the passed 2 months. I have about 2.65M shares at an avg around 0.0044

ReiShirouOfficial

My current play is txtm - Intent to retire in my 20s from it... Listen before judging this... https://preview.redd.it/v0b56v2v8knf1.png?width=689&format=png&auto=webp&s=eb47b070d4d3d70e55c028df11c0b6ceec90366f Q2 Assets doubled from 255m to 505m which by contract we are owed another 500m in assets thus doubling the balance sheet again. Paper wise we are trading at a 30m market cap with 505m+ in assets Waiting for PCAOB audit + sec reporting to be done at this moment. Backed by a prestigious chairmen who owns a farm half the size of paris which we will benefit from them soon A caveot emptor was removed so the only thing in the last 2 years was multiplying the balance sheet but ever since CE removal 3 months ago We learned we are finally hiring a PR firm / IR firm and advisory team People will bring up share structure but to get that out of the way, management has never diluted a share, and plan to uplist every share... Very great candidate for a long term buy and hold imo

______deleted__

“I hope I get the offer from IBM” said no talented CS/SWE/CE/AI graduate ever since the 2010s.

Roznadolina

If Liberty gets FDA approval, I honestly think MBOT could go way higher than people expect. We’re talking about the first remotely operated robotic system for endovascular procedures – that’s not just another “me-too” medtech, that’s a potential category creator. FDA approval would not only validate the technology but also open the doors to real hospital adoption in the US. From there, CE marking in Europe and approvals in other major markets (Japan, Middle East, LatAm) could follow. Each step would expand the TAM massively. Right now MBOT trades like a speculative microcap, but if Liberty proves itself clinically and commercially, you could easily see this rerating into small-mid cap territory over time. I don’t like throwing out exact numbers, but it’s not crazy to imagine multiples of the current market cap if adoption is successful. The real upside comes if Liberty establishes itself as a new standard of care in vascular robotics. That’s when you stop thinking in “hundreds of millions” and start thinking in “billions.” This is obviously high risk/high reward, but the potential runway here is enormous. If they execute, Liberty could take MBOT from being just another microcap ticker to a name everyone in medtech knows. 🚀

salty0waldo

Just wanted to add I was in DOW for a long time, terrible capital management that they are correcting. I exited prior to the previous quarter. I intend to re-enter this or next quarter. I am also eyeing LYB. A few other names are CC (refrigerant), EMN (vinyl), DD (speciality), CE (diverse)

ALQU1MISTA

I rather moved towards CE considering this year results. I would say that smaller companies will adapt better to current challenging conditions

salty0waldo

DOW and LYB are primarily commodities so polypropylene and polyethylene. They are hit hard by both tariffs and margin compression. CE, Westlake, and EMN have small commodity exposure. If the trough bottoms here, this is a nice base.

davewritescode

The magic has never been marketing, it’s been an impeccable sense of timing combined with nearly flawless technical execution. Apple has always been late to the game but when they enter a segment, they perfect it overnight. Portable MP3 players were a thing in the late 90s but the iPod was a revelation. Now instead of shuffling 10 songs onto a 128mb MP3 player I had my entire music library in my pocket. Same with the iPhone, nobody gave a shit about the bulky heavy Windows CE based phones or Sidekicks but when they iPhone came out it felt like a very viable useful product that made a real difference in day to day life. Microsoft had tablets in the early 2000s, but it wasn’t until the iPad came out that anyone cared about tablets. I have a feeling we’ll see history repeat itself here and it’s why I’m still a shareholder.

salty0waldo

Wow big gap down after reporting for CE, will have to dive in later. No positions here though, just following along.

salty0waldo

CE reports after close today, with how beaten down that sector has been hard to fathom a similar gap down like LYB, DOW, and EMN.

cowardunblockme

Was doing OK then covid hit and women started wearing yoga pants while shopping. Stock soared. New CEO arrived and started selling a workout mirror. When covid ended, people didn't want to work out at home. Plus sized women started wearing the pants and new manufacturers didn't have same quality. Pants looked see thru. New CE0 said They're not for everyone. Alienated many customers. Stock fell like a rock. New competition out hustled them for younger customers. Not sure what's been happening lately.

netflix-ceo

CE O no she di’nt

AntelopeSilver9351

I know,I know.   Gotta say,  more real estate though, n'est CE pas?

elegance78

Yeah, 95% of Russia still lives like if it the year was 450 CE...

Surprise_Typical

I'm so mad I could murder their CE....oh

PartTalker

True, but again... there are ways around that if the battery's starting energy density is significantly higher. For instance, Amprius batteries are far more likely to be used in eVTOLs because of the premium on gravimetric density. But there are also two more aspects of eVTOL use case that make the cycle life less important than EVs: 1) You do not drain the batteries to 100% depth of discharge because you'll always keep a 20-25% reserve to stay airborne. That puts a lot less stress on cycle life. 2) The packs will not be structural, so they wouldn't be planning to have them last 10+ calendar years like a Tesla. And while the cycle life is more of a problem in EVs, your battery management system could artificially use that extra starting capacity to mimic longer cycle life by limiting depth of discharge earlier in the pack's life and relaxing those limits as the battery pack ages. That would mean lower useful range early, but extend the range later in the vehicle's lifespan. Again, all with potentially having a higher range and better charging speed. Maybe. But yeah, silicon high energy anodes in mass-produced EVs is still problematic mostly due to the desired long calendar life. They are a much better use case fit for airborne use cases (drone, UAS, eVTOL) or replaceable use cases (LEV, CE).

Expensive-Ad7498

From an old 8K in 2021 (so keep in mind this is dated but just to illustrate that the graph you share is not relevant for mobile cells): EX-1: 900 Wh/L energy density 2022 EX-2: 1,030 Wh/L energy density 2023 EX-3: 1,255 Wh/L energy density 2025 [link to the 8K](https://ir.enovix.com/static-files/c1e1c4fe-ed73-43f9-8116-deb241613794) Take this with a grain of salt obviously this was before management change etc but they are already working on EX4M right now, safe to say these densities will be achieved and thats where the true value is. Im not even invested in ENVX for the potential EV value because its so far out, CE is the game

Expensive-Ad7498

Not really a competitor, 2 completely different markets. Also ampx cycle life is unusuable for CE and EV, and engineered silicon (amprius) is much more expensive than an architectural change that is material agnostic

Expensive-Ad7498

Ampx market is very limited as cycle life is unusable for EV and CE. Its good for EVTOL and drones but engineered silicon is always more expensive. ENVX has a much larger TAM with consumer electronics

ReiShirouOfficial

Lucky you then for holding, it’s go time, CE off and the operation is still going Q2 will be a bomb drop

ReiShirouOfficial

https://preview.redd.it/derxfcvj31ef1.png?width=714&format=png&auto=webp&s=e9947713c3235b9c1eaf76264d569eac1e25c021 JUST cause we didnt see it happen due to the CE, does not mean nothing was happening! He would not have bought 200 million shares and counting, with his own pocket money to lead the company to nothing... This is all all product...

ReiShirouOfficial

1) Not an issue, if its truly a unicorn we are going to the nasdaq, the expectation on the balance sheet on the Q2 in less than 30 days is over a billion if not multiple billion(s) 2) ackowledge this, 10 days after that press release they were put on ce (Caveot emptor), not tradable in the USA for 2.7 years, The thought is the PR was too big for a random penny stock they said "Woah this aint right", But after 2.7 years they came off the CE and none of the financials or tweets were taken down meaning it was all legit. Its not on the financials because the CE, so basically the company focused on multiply their inventory, as you can see we went from 15 million to 255 million... (Which now is probably in the billions), they spent 2 years strengenthing the balance sheet so now the big deal orders can come through.... (They became tradable again in the US 1.5 months ago). 3) Supply agreement bro, its inside that 2.3 million pound PR, Meaning its like a partnership we help fulfill the order with TXTM technology, cause we own extraction technology, we extract canabanoids for example out of the seeds and byproduct thus we can get revenue splits. And no its 255 million read the financials. UNDERSTAND 2023 was audited, currently we are getting a pcaob and form 10 audit to become sec complient IF THEY WERE A FRAUD, they OTC would have not relisted TXTM and taken the Caveot emptor off. https://preview.redd.it/fuwtkfo831ef1.png?width=778&format=png&auto=webp&s=8b3f2591f726e2ddbe63e06f0fbebece4d271989

BOOMHOTSTOCKS

Newegg Commerce, Inc. operates as an electronics-focused e-retailer in the United States, Canada, and internationally. The company offers desktops, laptops, gaming laptops, peripherals, and accessories; CPU/processors, graphic cards, motherboards, storage devices, and computer accessories; and software, virtual reality, gaming consoles, networking, digital games, home appliances, gaming desks/chairs, and TVs. It provides supply chain third-party services, such as Shipped by Newegg, offers warehousing and fulfillment services; Newegg Logistics, provides warehousing, inventory management, order processing, packing, and shipping; and Newegg Staffing, offers clerical, manufacturing, and logistics employee placement. In addition, the company operates B2C platforms, including Newegg.com, an online e-commerce platform; Newegg.ca, an e-commerce platform focusing on IT/CE products; and Newegg Global, as well as mobile apps; and B2B platforms comprising NeweggBusiness.com. It sells its products under the Asus, MSI, HP, Lenovo, Acer, Microsoft, Samsung, LG, Gigabyte, Logitech, Intel, AMD, MSI, Corsair, ASRock, Western Digital, Seagate, G.Skill, Meta, PlayStation, Dyson, Netgear, Nintendo, H&R Block, and Adobe brands. The company was founded in 2001 and is headquartered in Diamond Bar, California. Newegg Commerce, Inc. is a subsidiary of Digital Grid (Hong Kong) Technology Co., Ltd.

salty0waldo

lol DOW/LYB/OLN/CE at this point just need to declare bankruptcy...

Red_Zone_Broly

#"Iran is weeks away from having nukes..." #- The Council of Nicaea, May 325 CE

netflix-ceo

CE Oh no they di’nt

FuckElonMuskkk

Lmao it's Sergeant Johnson from Halo: CE

JudgmentvsChemical

To name a few of them **Greco-Persian Wars** (499–449 BCE) - **Wars of Alexander the Great** (335–323 BCE) - **Roman-Parthian Wars** (66 BCE–217 CE) - **Byzantine-Sassanid Wars** (502–628 CE) - **Arab Conquests** (7th–8th centuries CE) - **Crusades** (1096–1291 CE) - **Ottoman Wars** (1299–1922 CE) - **Middle Eastern Theatre of World War I** (1914–1918) - **Arab Revolt** (1916–1918) - **Israeli-Arab Wars** (1948–present) - **Iran-Iraq War** (1980–1988) - **Gulf War** (1990–1991) - **Iraq War** (2003–2011) - **Syrian Civil War** (2011–present) - **Yemeni Civil War** (2014–present) That's not even mentioning that knights of Templar and the Crusades that centered around Isreal and Jerusalem **Siege of Jerusalem (1187)** - **Battle of Hattin (1187)** - **Siege of Acre (1191)** - **Battle of Arsuf (1191)** - **Battle of Mansurah (1250)** - **Siege of Acre (1291)** They been fighting for one reason or another since the beginning of time it seems.

netflix-ceo

CE Oh no he di’nt

WinterHill

There were more than one generation of Microsoft phones. Ever use Windows CE? It was the precursor to the “Microsoft phone”. And it was next levels of awful. The thing it was really bad at was being a phone. It did other stuff ok.

MaxBlackAUT

INBS a rough couple of weeks are behind us. They have a working product, they are CE certified in EU and it’s missing the FDA approval. Once this is here I’m certain this could go mental. Anyways good luck to you all!

HiJustWhy

Joseph was descended from cleopatra, not mary. Altho there is evidence even she was a follower of Isis: ‘worship of Isis was ended by the rise of Christianity in the fourth through sixth centuries CE. Her worship may have influenced Christian beliefs and practices such as the veneration of Mary’ Similarities between Isis and Mary, the mother of Jesus, have also been scrutinized. Protestants have argued that Catholic veneration of Mary is a remnant of paganism. R. E. Witt saw Isis as the "great forerunner" of Mary. He suggested converts to Christianity who had formerly worshipped Isis would have seen Mary in much the same terms as their traditional goddess. He pointed out that the two had several spheres of influence in common — agriculture and protection of sailors. He compared Mary's title "Mother of God" to Isis's epithet "mother of the god", and Mary's "queen of heaven" to Isis's "queen of heaven". John McGuckin, a church historian, says that Mary absorbed superficial traits from goddesses, such as iconography. Images of Isis with Horus in her lap are often suggested as an influence on the iconography of Mary, particularly images of Mary nursing the infant Jesus, as images of nursing women were rare in the ancient Mediterranean world outside Egypt. Vincent Tran Tam Tinh points out that the latest images of Isis nursing Horus date to 4th century CE, while the earliest images of Mary nursing Jesus date to the 7th century CE. Sabrina Higgins, drawing on his study, argues that if there is a connection between the iconographies of Isis and Mary, it is limited to images from Egypt. Thomas F. Mathews and Norman Muller think Isis's pose in late antique panel paintings influenced several types of Marian icons, inside and outside Egypt. Elizabeth Bolman says these early Egyptian images of Mary nursing Jesus were meant to emphasize his divinity, much as images of nursing goddesses did in ancient Egyptian iconography. Higgins argues that such similarities prove that images of Isis influenced those of Mary

PantaRheiExpress

Nero did not end Roman hegemony. He died in 68 CE, the empire reached its largest geographic extent in 117 CE, went through a series of catastrophes in the 3rd century, and then finally ended in 476 CE, while the Eastern Empire endured for another 1,000 years. I agree with your point about narcissistic leaders, and Nero certainly caused some problems, but he can’t be single-handedly blamed for what happened to Rome.

Ballroom150478

The man is and remains a clueless moron. VAT is applied to everything. Foreign as well as domestic products. It's a sales tax. Safety standards is something the US has too, but I suppose you can argue that the CE and cUL, for instance, are intangible trade barriers. The deficit he's mentioning, is based on not including services. If you include those, the deficit drops to...I think it's around 60 billion, as the US runs a MASSIVE surplus on those things, pretty much everywhere. And so on.

salty0waldo

Basic materials, specifically plastics (polyethylene, polypropylene) like DOW, LYB, BASF, CE are literally just straight down stocks at this point. With so much macro-economic uncertainty layered atop already lowing demand this cohort likely will continue to see their market caps shrink. This is just crazy to me, and yes I get the business sector is very cyclic but this entire sector is pricing in not just recession but entire depression in that industry. Crazy. These are pretty big companies as well that employee alot of jobs. It is likely that even after most of these names being cut in half over the past 12 months, that their market caps today are still going to be peak from 5 years out. Wild.

Field_Sweeper

And you know what, just about everything that comes here from China is ignoring laws, dangerous chemicals, Fake UL or CE listing etc. So I honestly don't even care a lick about anything China.

does-this-work1991

Not if ~50% of all spending is being done by the top 10% of income earners. By definition consumer spending is done by the broad public because everyone consumes. That said, I should’ve rephrased and say that simply a small number of households are driving continued overall spending growth. Instead of seeing 50% of spending driven by say the top 30% or 40% of income households it’s concentrated to top 10%. Indicating that the bottom 90% income households (the overwhelming majority of Americans households) aren’t driving spending and are continuing to represent a smaller share of spending as has been the case since the early 2000s. The point you’re making about the bottom portion of households still spending but spending more of their relative take home though is something that should be highlighted in addition in the article and analysis. That can also be backed up with BLS CE survey data

Ok_Farmer_7204

My plan is to load up at the lowest levels, sell some at the highs if an interim spike happens, and then reload after any dilutive events -Because at that point, not only will they have all of that positive development, they'll also have a stronger cash balance and a clear runway into the U.S. market. Their product is already CE -marked and in commercial use in EU, so this stock (unlike many other hyped-up stocks around here) to me seems like it has some deeper value.

luvs_spaniels

Inflation is a lagging indicator. By the time it is reported, the data in the report is several months to 2 years old. "There is a time lag between the expenditure survey and its use in the CPI. For example, CPI data in 2023 was based on data collected from the Consumer Expenditure Surveys (CE) for 2021." [Consumer Price Index FAQs - BLS](https://www.bls.gov/cpi/questions-and-answers.htm) It is highly likely most, if not all, of the data in the latest CPI report was collected during Biden's time in office, meaning before the first tariff increase. The media gives credit for the report to whoever is in office when its published. That's why inflation looked normal when people were complaining about housing costs in 2020. Anyone who bought groceries knew prices were going up months before the inflation report showed anything. That's why there are articles like [this one from the Kansas City Fed](https://fedinprint.org/item/fedker/31331#:~:text=Prominent%20leading%20indicators%20of%20inflation,to%20predict%20the%20inflation%20rate.%3E) about leading indicators for inflation. Modeling inflation projections is always interesting, often wrong, and rather cutting edge. By that, I mean Central Banks and economists are more likely to publish how they constructed the latest model than ongoing results.

MELOFINANCE

In 2005, Toyota offered several vehicles with starting prices under $15,000, appealing to budget-conscious buyers. Here’s a breakdown of those models: ⸻ 🚗 2005 Toyota Echo The Echo was Toyota’s most affordable model in 2005, known for its simplicity and fuel efficiency. • Base Coupe (Manual): $10,455 • Base Sedan (Manual): $10,985 • Base Coupe (Automatic): $11,255 • Base Sedan (Automatic): $11,785  All Echo trims were well below the $15,000 mark, making them an economical choice for drivers seeking reliability and excellent fuel economy. ⸻ 🚙 2005 Toyota Corolla The Corolla, a perennial favorite for its reliability, had several trims priced under $15,000: • CE (Manual): $13,780 • CE (Automatic): $14,580 • S (Manual): $14,825 • LE (Manual): $14,990   These trims offered a balance of comfort and efficiency, with the CE being the most budget-friendly option.  ⸻ 🛻 2005 Toyota Matrix The Matrix combined the practicality of a hatchback with the efficiency of a compact car. While most trims were above $15,000, the base model with manual transmission was just under: • Base 2WD (Manual): $14,860  This model provided versatility and cargo space, appealing to those needing more room without a significant price increase.  ⸻ 🚗 2005 Scion xA and xB Scion, Toyota’s youth-oriented brand, offered the xA and xB models, both starting under $15,000:  • Scion xA: Starting at approximately $12,480 • Scion xB: Starting at approximately $13,680  These models were known for their unique designs and customization options, targeting younger buyers seeking affordable and distinctive vehicles.  ⸻ Summary Model Starting MSRP Notes Toyota Echo $10,455 Most affordable, excellent fuel economy Toyota Corolla CE $13,780 Reliable compact sedan Toyota Matrix Base $14,860 Versatile hatchback Scion xA ~$12,480 Youthful design, compact hatchback Scion xB ~$13,680 Boxy design, spacious interior These options provided a range of choices for buyers in 2005, all under the $15,000 threshold, combining Toyota’s reputation for reliability with affordability.

Human-Worldliness999

Chinese news sources and social media predominantly present pro-Pakistan content, which tends to be well-received by Chinese netizens. Currently, the claim of 5 or 6 jets being shot down originates solely from a Pakistani source. While India hasn't confirmed or denied this, one leaked video footage shows debris clearly identifiable as belonging to a French-made aircraft. Due to restrictions on F-16 usage (limited to self-defense), Pakistan would likely have used a Chinese-designed/manufactured aircraft, either JF-17, J-10CE, or HQ-9 anti-aircraft missile. This plus the recent reports of China equipping the Pakistani Air Force with the full-fledged PL15 missile (not the export version) naturally create the impression that Chinese jets and missiles are actually capable of matching or even surpassing western-made counterparts, especially when people used to have the impression that Chinese made are just inferior knockoffs, and these altogether create more optimistism over the potential oversea markets of these Chinese made weapons.

BIP3N

What time is CE earnings?

BIP3N

PLTR? **CALLS** CELH? **PUTS** HIMS? **CALLS** CE? **CALLS** Easiest 50 bagger of the day. 

Baymax702

P.S. While all my friends post education were going to bars, picking up chicks, etc. I was busy using all of my young energy to create a successful business, working, and lots of CE, and my first investment was AMD when it was ~$2/share in 2009. Many of these friends fell off, but now they are working and barely enjoy their time. I work to make more time.

_hiddenscout

$LMAT Q1 Sales grew 12% to $59.9M with strong organic growth of 13% Gross margin improved to 69.2% (+60 bps) due to higher pricing and efficiencies Strong regional performance with EMEA sales up 18% and Americas up 11% Artegraft received MDR CE Mark approval, enabling European expansion Increased 2025 guidance: Sales to $245M (+12%) and EPS to $2.16 (+12%) Robust cash position of $302.5M, up $2.8M sequentially $75M share repurchase program authorized Chairman/CEO George LeMaitre said, “Q1 sales momentum allows us to increase our 2025 reported ($245mm) and organic (+13%) sales guidance, up from prior guidance of $239mm and 10%. $303mm of cash also provides strategic optionality.”

EveryRedditorSucks

Fuck Tesla - but Ford’s short term future prospects look incredibly dim. They recently cancelled their 3-row EUV, then officially cancelled their entire 4th gen electrical architecture. The P800 program (next gen Lightning) has been delayed numerous times and rumors are it may too be cancelled. At this point, CE1 is literally the only thing that can save Model E, imo. Otherwise I expect we’re looking at a full change in leadership from the top down. I strongly support union labor but the fact is Ford as a company hasn’t innovated jack shit in 5 full years at this point. They are so far behind the competition it’s laughable.

11Mikky11

That's because it's absolutely vast with different tariff rates for so many different goods or products from different countries or regions. Here are some rates here https://www.wto.org/english/res_e/statis_e/daily_update_e/tariff_profiles/CE_e.pdf

Altruistic-Car2880

There’s always a profit to be made. Follow the money. Cargill and CHS will profit from any corn and soybean sales that migrate to Brazil and South America from US. [Nutrien has entered the chat.](https://www.bing.com/fd/ls/GLinkPing.aspx?IG=1F697BA91C2A443E90BCEED0337268CE&&ID=SERP,5470.1&SUIH=fJK8raxWR6A8EAgc0VSknw&redir=aHR0cHM6Ly9lbi53aWtpcGVkaWEub3JnL3dpa2kvTnV0cmllbg)

Ozotso

2031CE. I’ve made a quarter million off SPY puts. I withdraw all my funds to buy a cooler and a sack of salt for $230,000.

whatarenumbers365

I’m a CE, that has never been my experience, civil sees it dead last. It’s not till public funding dries up. Also business right now booming, they can’t hire engineers fast enough. Maybe you’re in land development, and more focused on the commercial side.

No_Communication8613

It's not too early. This was just announced today. https://www.globenewswire.com/news-release/2025/04/23/3066719/0/en/Perspective-Therapeutics-Announces-Acceptance-of-VMT-%CE%B1-NET-and-VMT01-Data-for-Presentation-at-the-2025-ASCO-Annual-Meeting.html I want it to dip a bit before I get in.

xorfivesix

Trump looks CE to me, what with the 34 felonies and SA.

The_Keg

Because trashes like you keep spewing literally false populist piece of shit rhetorics. I didnt vote for Trump. Whats next? CE